PANTHER™ Pathway Release Calendar
PANTHER Pathways
version 1.3 release in August 2006
- 23 new pathways, 130 total
new pathways include:
- Adenine and hypoxanthine salvage pathway (P02723)
- Androgen/estrogene/progesterone biosynthesis (P02727)
- Biotin biosynthesis (P02731)
- Cobalamin biosynthesis (P02735)
- Formyltetrahydroformate biosynthesis (P02743)
- Histidine biosynthesis (P02747)
- Lysine biosynthesis (P02751)
- Methylmalonyl pathway (P02755)
- Pyridoxal-5-phosphate biosynthesis (P02759)
- Peptidoglycan biosynthesis (P02763)
- Phenylpropionate degradation (P02764)
- Pyrimidine Metabolism (P02771)
- Salvage pyrimidine ribonucleotides (P02775)
- Thiamin biosynthesis (P02779)
- Tryptophan biosynthesis (P02783)
- Vitamin B6 metabolism (P02787)
- Beta1 adrenergic receptor signaling pathway (P04377)
- Beta2 adrenergic receptor signaling pathway (P04378)
- Beta3 adrenergic receptor signaling pathway (P04379)
- Gamma-aminobutyric acid synthesis (P04384)
- Histamine H1 receptor mediated signaling pathway (P04385)
- Histamine H2 receptor mediated signaling pathway (P04386)
- Histamine synthesis (P04387)
- PANTHER Pathways version 2.0 release
in May 2007
- Improved Pathway Applet which is compatible with CellDesigner 3.1.
- 9 new pathways, 139 total
new pathways include:
- 2-arachidonoylglycerol biosynthesis (P05726)
- Anandamide biosynthesis (P05727)
- Anandamide degradation (P05728)
- Bupropion degradation (P05729)
- Nicotine degradation I (P05732)
- Nicotine degradation II (P05733)
- Endogenous cannabinoid signaling (P05730)
- GABA-B receptor II signaling (P05731)
- Synaptic vesicle trafficking (P05734)
- PANTHER Pathways version 2.1 release
in December 2007
- 31 new pathways, 165 total
new pathways include:
- Alanine biosynthesis (P02724)
- Angiotensin II-stimulated signaling through G proteins and beta-arrestin (P05911)
- Arginine biosynthesis (P02728)
- Coenzyme A biosynthesis (P02736)
- Coenzyme A linked carnitine metabolism (P02732)
- De novo pyrimidine deoxyribonucleotide biosynthesis (P02739)
- De novo pyrimidine ribonucleotides biosythesis (P02740)
- Dopamine receptor mediated signaling pathway (P05912)
-- replace:
D1/D5 dopamine receptor mediated sigaling pathway (P04381)
D2/D3/D4 dopamine receptor mediated signaling pathway (P04382)
- Enkephalin release (P05913)
-- replace:
Enkephalin release (P04383)
- Fructose galactose metabolism (P02744)
- Isoleucine biosynthesis (P02748)
- Mannose metabolism (P02752)
- N-acetylglucosamine metabolism (P02756)
- Nicotine degradation (P05914)
-- replace:
Nicotine degradation I (P05732)
Nicotine degradation II (P05733)
- Opioid prodynorphin pathway (P05916)
- Opioid proenkephalin pathway (P05915)
- Opioid proopiomelanocortin pathway (P05917)
- Oxytocin receptor mediated signaling pathway (P04391)
- PRPP biosynthesis (P02760)
- Phenylpropionate degradation (P02767)
- Proline biosynthesis (P02768)
- Pyruvate metabolism (P02772)
- Serine glycine biosynthesis (P02776)
- Thiamin metabolism (P02780)
- Thyrotropin-releasing hormone receptor signaling pathway (P04394)
- Tyrosine biosynthesis (P02784)
- Vasopressin synthesis (P04395)
- Vitamin D metabolism and pathway (P04396)
- Xanthine and guanine salvage pathway (P02788)
- p38 MAPK pathway (P05918)
- p53 pathway by glucose deprivation (P04397)
If you have any questions, comments, or suggestions please
contact us.
